Table III.
Complement regulation by human complement-regulatory gene expression |
CD46 (membrane cofactor protein) |
CD55 (decay-accelerating factor) |
CD59 (protectin or membrane inhibitor of reactive lysis) |
Gal or non-Gal antigen “masking” or deletion |
Human H-transferase gene expression (expression of blood type O antigen) |
Endo-β-galactosidase C (reduction of Gal antigen expression) |
α(1,3)-galactosyltransferase gene-knockout (GTKO) |
Cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMAH) gene-knockout (CMAHKO) |
β4GalNT2 (β(1,4)-N-acetylgalactosaminyltransferase) gene-knockout (β4GalNT2KO) |
Suppression of cellular immune response by gene expression or downregulation |
CIITA-DN (MHC class II transactivator knockdown, resulting in swine leukocyte antigen class II knockdown) |
Class I MHC-knockout (MHC-IKO) |
HLA-E/human β2-microglobulin (inhibits human natural killer cell cytotoxicity) |
Human FAS ligand (CD95L) |
Human N-acetylglucosaminyltransferase III gene |
Porcine CTLA4-Ig (cytotoxic T-lymphocyte antigen 4 or CD152) |
Human tumor necrosis factor-α-related apoptosis-inducing ligand |
Anticoagulation and anti-inflammatory gene expression or deletion |
von Willebrand factor-deficient (natural mutant) |
Human tissue factor pathway inhibitor |
Human thrombomodulin |
Human endothelial protein C receptor |
Human CD39 (ectonucleoside triphosphate diphosphohydrolase-1) |
Anticoagulation, anti-inflammatory, and anti-apoptotic gene expression |
Human A20 (tumor necrosis factor-α-induced protein 3) |
Human heme oxygenase-1 |
Human CD47 (species-specific interaction with SIRP-α inhibits phagocytosis) |
Porcine asialoglycoprotein receptor 1 gene-knockout (decreases platelet phagocytosis) |
Human signal regulatory protein α (decreases platelet phagocytosis by “self”-recognition) |
Prevention of porcine endogenous retrovirus (PERV) activation |
PERV siRNA |
Modified from Cooper et al. (2016).